STOCK TITAN

Hawkins, Inc. Reports First Quarter Fiscal 2027 Results

(Positive)
Tags

Hawkins (Nasdaq: HWKN) reported first quarter fiscal 2027 revenue of $315.7 million, up 8% year over year, with all segments growing: Water Treatment +6% to $158.3 million, Food & Health Sciences +9% to $97.3 million, and Industrial Solutions +10% to $60.1 million.

Gross profit reached a record $74.0 million (23% margin), up 2%, while diluted EPS declined 4% to $1.35 and net income fell 3% to $28.3 million. Adjusted EBITDA rose 1% to a record $56.9 million. Free cash flow increased over 30% to $23.5 million, supporting $7.0 million of share repurchases, $4.0 million in dividends and the $3.6 million acquisition of Aqua-Chem to expand the Water Treatment footprint. Total debt was $244.0 million with a leverage ratio of 1.36x trailing twelve‑month adjusted EBITDA.

Loading...
Loading translation...

Positive

  • Record quarterly revenue $315.7 million, up 8% year over year
  • Segment sales growth: Water Treatment +6%, Food & Health Sciences +9%, Industrial Solutions +10%
  • Record adjusted EBITDA $56.9 million, up 1% year over year
  • Free cash flow up over 30% to $23.5 million in Q1
  • Returned capital via $7.0 million share repurchases and $4.0 million dividends
  • Acquired Aqua-Chem for $3.6 million to support Water Treatment growth
  • Leverage ratio modest at 1.36x trailing twelve‑month adjusted EBITDA

Negative

  • Net income down 3% to $28.3 million and diluted EPS down 4% to $1.35
  • Gross margin compressed from 25% to 23%, pressured by LIFO and freight costs
  • SG&A expenses up 14% to $35.3 million, partly from acquisitions and non‑recurring comparisons

News Explained

At June 28, 2026, cash was $7,977 against $244.0 million debt; earnings faced LIFO, freight, and acquired-cost pressures.

The quarter ended June 28 is now reported; Hawkins held $7,977 of cash against $244.0 million of debt, leaving the disclosed liquidity position defined by those balances.

Reported gross profit was affected by a $1.9 million increase in the LIFO reserve and about $1.3 million of unrecovered freight costs; SG&A also rose $4.3 million, including $2.1 million from acquired businesses and the absence of a prior $1.9 million favorable earnout adjustment.

Market Context

The prior fiscal 2026 earnings release was followed by -3.25% in 24 hours, showing that reported rec...
Analysis

The prior fiscal 2026 earnings release was followed by -3.25% in 24 hours, showing that reported records did not ensure positive follow-through. This quarter's cash-flow gains should be weighed against lower EPS and margin pressures.

Key Figures

Revenue: $315.7M Gross Profit: $74.0M Diluted EPS: $1.35 +5 more
8 metrics
Revenue $315.7M Q1 fiscal 2027; up 8% year over year
Gross Profit $74.0M Q1 fiscal 2027; up 2% year over year
Diluted EPS $1.35 Q1 fiscal 2027; down $0.05 or 4% year over year
Net Income $28.3M Q1 fiscal 2027; down 3% year over year
Adjusted EBITDA $56.9M Q1 fiscal 2027; up 1% year over year
Operating Cash Flow $35.2M Q1 fiscal 2027; up 12% year over year
Free Cash Flow $23.5M Q1 fiscal 2027; increased over 30% year over year
Aqua-Chem Acquisition $3.6M Acquisition completed during Q1 fiscal 2027

Historical Context

5 past events · Latest: Jul 15 (Neutral)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jul 15 Earnings date notice Neutral +3.0% Scheduled first-quarter fiscal 2027 results release for July 29 after market close
May 13 Annual earnings report Positive -3.3% Reported record fiscal 2026 sales, gross profit, adjusted EBITDA, and operating cash flow
May 13 Dividend declaration Positive -3.3% Declared quarterly cash dividend of $0.19 per share payable June 12
Apr 30 Aqua-Chem acquisition Positive +0.0% Completed Aqua-Chem asset acquisition supporting Water Treatment expansion in Nebraska and Iowa
Apr 29 Earnings date notice Neutral -0.9% Scheduled fourth-quarter and fiscal 2026 results release for May 13

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent earnings coverage diverged from reported operating results, with the May 13 earnings release followed by a -3.25% reaction despite record fiscal-year results.

Key Terms

adjusted ebitda, lifo reserve, free cash flow, leverage ratio, +1 more
5 terms
adjusted ebitda financial
"Record adjusted EBITDA, a non-GAAP measure, of $56.9 million"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
lifo reserve financial
"During the current quarter, the LIFO reserve increased"
The LIFO reserve is the difference between a company's inventory value under the LIFO method (last items in are treated as sold first) and what that inventory would be worth under FIFO (first items in are sold first). Think of it as the accounting gap that shows how older or newer costs are hiding in inventory; investors use it to compare firms using different methods, assess hidden profits or tax effects, and understand how rising or falling prices may distort reported earnings.
free cash flow financial
"Free cash flow, defined as net cash provided by operating activities"
Free cash flow is the amount of money a company has left over after paying all its expenses and investing in its business, like buying equipment or updating facilities. It shows how much cash is available to reward shareholders, pay down debt, or save for future growth. This helps investors understand if a company is financially healthy and able to grow.
View in glossary
leverage ratio financial
"our leverage ratio at the end of the first quarter was 1.36x"
Leverage ratio measures how much a company relies on borrowed money compared with its own funds or assets, typically expressed as debt relative to equity or total assets. Like a homeowner with a mortgage, higher leverage can amplify returns when business is strong but also raises the chance of big losses or default if revenue falls, so investors use it to judge financial risk and resilience.
View in glossary
non-gaap financial
"adjusted EBITDA, a non-GAAP measure"
Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.
View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ROSEVILLE, Minn., July 29, 2026 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three months ended June 28, 2026, its first quarter of fiscal 2027.

First Quarter Fiscal Year 2027 Highlights:

(All comparisons are to the first quarter of fiscal 2026 unless otherwise noted.)

  • Record first quarter revenue of $315.7 million, with growth of 8%, driven by increased sales across all segments, including Water Treatment segment growth of 6%, Food & Health Sciences segment growth of 9%, and Industrial Solutions segment growth of 10%.
  • Record first quarter gross profit of $74.0 million, an increase of 2%.
  • Diluted earnings per share ("EPS") of $1.35 decreased $0.05, or 4%.
  • Net income of $28.3 million decreased 3%, with trailing twelve-month net income of $80.6 million. Record Earnings Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a non-GAAP measure, of $56.9 million, a 1% increase. Trailing twelve-month adjusted EBITDA of $179.8 million.
  • Generated operating cash flow of $35.2 million, an increase of 12%. Free cash flow, defined as net cash provided by operating activities less capital expenditures, increased over 30%, to $23.5 million, which we allocated to repurchasing $7.0 million of stock, paying $4.0 million in dividends, and acquiring Aqua-Chem, Inc. for $3.6 million.
  • We continued to execute on our Water Treatment growth strategy with the purchase of Aqua-Chem, Inc., a distributor of water treatment products mainly in Nebraska and Iowa.

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

“Our first quarter was a solid start to the year, highlighted by another quarter of record results in revenue, gross profit, and adjusted EBITDA” said Patrick Hawkins, Chief Executive Officer and President. “Our record revenue of $315.7 million was the result of all three reporting segments growing year over year, and included organic revenue growth of approximately 5%, consistent with our expectation of returning to historical organic revenue growth rates in fiscal 2027.”

Mr. Hawkins continued, “The first quarter brought raw material volatility. Our great team members stayed close to our suppliers and our customers, managing input costs while continuing to deliver the products and level of service expected from Hawkins. As we exited the quarter, raw material costs had largely stabilized.”

Mr. Hawkins concluded, “Our balance sheet remains strong, and our leverage ratio at the end of the first quarter was 1.36x adjusted EBITDA. We continue to generate strong free cash flow and we expect to continue to pay down debt during fiscal 2027. We will also continue to deliver on our strategy of investing in our higher-margin businesses, acquiring companies that are accretive to Hawkins, and servicing the needs of our customers to the highest level possible.”

First Quarter Financial Highlights:

NET INCOME

For the first quarter of fiscal 2027, we reported net income of $28.3 million, or $1.35 per diluted share, compared to net income for the first quarter of fiscal 2026 of $29.2 million, or $1.40 per diluted share.

REVENUE

Sales were $315.7 million for the first quarter of fiscal 2027, an increase of $22.4 million, or 8%, from sales of $293.3 million in the same period a year ago. All of our segments grew by more than 5% from the same period a year ago.

Water Treatment segment sales increased $8.7 million, or 6%, to $158.3 million for the current quarter, from $149.6 million in the same period a year ago. Water Treatment sales increased as a result of $6.9 million of added sales from acquired businesses, as well as increased organic sales volumes and improved pricing on certain products in our legacy business, including continued growth in our proprietary product lines.

Food & Health Sciences segment sales increased $8.1 million, or 9%, to $97.3 million for the current quarter, from $89.2 million in the same period a year ago. Sales of our agricultural, nutrition, and pharmaceutical products all increased over the same period a year ago, partially offset by decreased sales volumes of our food ingredient products. Agricultural products remained a source of strength, with sales growth of 30% driven by higher volumes.

Industrial Solutions segment sales increased $5.6 million, or 10%, to $60.1 million for the current quarter, from $54.5 million in the same period a year ago. Industrial Solutions segment sales increased primarily as a result of increased sales volumes of certain of our manufactured, blended and repackaged products.

GROSS PROFIT

Gross profit increased $1.6 million, or 2%, to $74.0 million, or 23% of sales, for the current quarter, from $72.4 million, or 25% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $1.9 million, a $1.3 million greater headwind than in the same period a year ago. In addition to the impact of the LIFO reserve, gross margin was pressured by higher freight costs of approximately $1.3 million that were not fully recovered through freight charges billed to customers.

Gross profit for the Water Treatment segment increased $1.7 million, or 4%, to $45.5 million, or 29% of sales, for the current quarter, from $43.7 million, or 29% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased by $0.5 million, a $0.3 million greater headwind than in the same period a year ago. The increase in gross profit was primarily driven by higher sales partially offset by higher LIFO and freight costs.

Gross profit for the Food & Health Sciences segment was $19.3 million for the current quarter, unchanged from the same period in the prior year. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.8 million, a $0.6 million greater headwind than in the same period a year ago. The benefit of higher sales volumes was offset by higher LIFO and freight costs.

Gross profit for the Industrial Solutions segment of $9.2 million, or 15% of sales, for the current quarter, was relatively flat compared to $9.3 million, or 17% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.7 million, a $0.5 million greater headwind than in the same period a year ago. The benefit of higher sales volumes was more than offset by higher LIFO and freight costs.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

Selling, general and administrative (“SG&A”) expenses increased $4.3 million, or 14%, to $35.3 million, or 11% of sales, for the current quarter, from $31.0 million, or 11% of sales, in the same period a year ago. This included $2.1 million due to added costs from the acquired businesses in our Water Treatment segment. In addition, the prior-year period included a $1.9 million favorable fair value adjustment that reduced SG&A, reflecting a downward revision to the estimated Water Solutions earnout liability based on a change in projected estimates related to the earnout target. This benefit did not recur in the current period, resulting in a $1.9 million year-over-year increase in SG&A. SG&A also included a $0.5 million incremental increase in non-qualified deferred compensation expense, which was offset by a corresponding gain within other income. These increases were partially offset by lower acquisition-related costs and other changes across our operating expenses.

ADJUSTED EBITDA

Adjusted EBITDA, a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of adjusted EBITDA is presented below. Adjusted EBITDA for the three months ended June 28, 2026 was $56.9 million, an increase of $0.8 million, or 1%, from $56.1 million in the same period a year ago. In the third quarter of fiscal 2026, we revised our definition of adjusted EBITDA to exclude non-cash earnout related expense and income, in order to better reflect results from operations. Prior-year adjusted EBITDA has been recast in accordance with the current definition. As originally reported, adjusted EBITDA for the three months ended June 29, 2025 was $57.6 million, which included non-cash earnout related income that is excluded under the current definition.

INCOME TAXES

Our effective income tax rate was 24% for the current quarter and 25% for the same period a year ago. The effective tax rate in both years was impacted by favorable tax provision adjustments recorded. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes. Our effective tax rate for the full year is expected to be approximately 25% to 27%.

BALANCE SHEET

As of June 28, 2026, our working capital was $13 million higher than the end of fiscal 2026 due primarily to increased trade receivables. Our total debt outstanding at the end of the first quarter was $244.0 million, and our leverage ratio was 1.36x our trailing twelve-month adjusted EBITDA, as compared to 1.37x our trailing twelve-month adjusted EBITDA at the end of fiscal 2026.

About Hawkins, Inc.

Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for its Water Treatment, Food & Health Sciences, and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 66 facilities in 28 states and creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated approximately $1.1 billion of revenue in fiscal 2026 and has approximately 1,200 employees. For more information, including registering to receive email alerts, please visit www.hawkinsinc.com/investors.

Reconciliation of Non-GAAP Financial Measures

We report our consolidated financial results in accordance with U.S. generally accepted accounting principles (GAAP). To assist investors in understanding our financial performance between periods, we have provided certain financial measures not computed according to GAAP, including adjusted EBITDA and free cash flow. These non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures. The method we use to produce non-GAAP results is not computed according to GAAP and may differ from the methods used by other companies.

Management uses these non-GAAP financial measures internally to understand, manage and evaluate our business and to make operating decisions. Management believes that these non-GAAP financial measures reflect an additional way of viewing aspects of our operations that, when viewed with our GAAP results, provide a more complete understanding of the factors and trends affecting our financial condition and results of operations.

We define adjusted EBITDA as GAAP net income adjusted for the impact of the following: net interest expense resulting from our net borrowing position; income tax expense; non-cash expenses including amortization of intangibles, depreciation, charges for the employee stock purchase plan and restricted stock grants, non-recurring items of income or expense, and earnout-related expense or income. The non-cash earnout related expense or income adjustment was added to our definition in the third quarter of fiscal 2026 to better reflect results from operations. Prior period amounts have been recast to conform to the current definition.

We define free cash flow as net cash provided by operating activities less purchases of property, plant, and equipment. Management believes free cash flow is a useful measure of the cash generated by our business that is available for, among other things, debt repayment, acquisitions, dividends, and share repurchases.

Adjusted EBITDA Three months ended Trailing twelve months ended
(In thousands) June 28,
2026
 June 29,
2025
 June 28,
2026
 June 29,
2025
Net Income (GAAP) $28,254 $29,175  $80,627  $84,641 
Interest expense, net  2,773  3,269   13,011   7,438 
Income tax expense  9,070  9,831   27,031   30,061 
Amortization of intangibles  5,516  4,821   21,987   14,783 
Depreciation expense  8,429  7,470   32,209   28,127 
Non-cash compensation expense  2,235  2,212   8,596   7,243 
Non-recurring acquisition expenses(1)  63  870   432   1,911 
Non-cash earnout related expense (income)  535  (1,583)  (4,059)  (553)
Adjusted EBITDA $56,875 $56,065  $179,834  $173,651 


(1) Acquisition expenses consist of legal, professional, and other direct costs incurred in connection with business acquisitions. These costs are transaction-specific and not part of normal recurring operations.


Free Cash Flow Reconciliation Three months ended
(In thousands) June 28,
2026
June 29,
2025
Net cash provided by operating activities $35,152 $31,490 
Less: Purchases of property, plant & equipment  (11,605) (13,544)
Free cash flow $23,547 $17,946 


HAWKINS, INC.
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
(In thousands, except share and per-share data)
 
  Three months ended
  June 28,
2026
 June 29,
2025
Sales $315,675  $293,272 
Cost of sales  (241,668)  (220,910)
Gross profit  74,007   72,362 
Selling, general and administrative expenses  (35,335)  (31,029)
Operating income  38,672   41,333 
Interest expense, net  (2,773)  (3,269)
Other income  1,425   942 
Income before income taxes  37,324   39,006 
Income tax expense  (9,070)  (9,831)
Net income $28,254  $29,175 
     
Weighted average number of shares outstanding - basic  20,777,481   20,717,485 
Weighted average number of shares outstanding - diluted  20,853,991   20,810,562 
     
Basic earnings per share $1.36  $1.41 
Diluted earnings per share $1.35  $1.40 
     
Cash dividends declared per common share $0.19  $0.18 


HAWKINS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In thousands, except share data)
 
  
  June 28,
2026
  March 29,
2026
 
ASSETS      
CURRENT ASSETS:      
Cash and cash equivalents $7,977  $3,914 
Trade accounts receivables, net  151,773   139,796 
Inventories  79,864   78,199 
Prepaid expenses and other current assets  9,165   9,556 
           Total current assets  248,779   231,465 
Property, plant, and equipment  501,792   489,662 
Less accumulated depreciation  231,206   223,406 
           Net property, plant, and equipment  270,586   266,256 
OTHER ASSETS:      
Right-of-use assets  16,081   16,840 
Goodwill  223,828   223,042 
Intangible assets, net  229,018   232,887 
Deferred compensation plan asset  16,477   12,812 
Other  1,474   2,988 
         
           Total other assets  486,878   488,569 
           Total assets $1,006,243  $986,290 
LIABILITIES AND SHAREHOLDERS’ EQUITY      
CURRENT LIABILITIES:      
Accounts payable — trade $62,845  $59,835 
Accrued payroll and employee benefits  15,750   20,092 
Income tax payable  8,236   98 
Environmental remediation  7,700   7,700 
Other current liabilities (Note 8)  15,083   17,119 
           Total current liabilities  109,614   104,844 
LONG-TERM LIABILITIES:      
Long-term debt  244,000   244,000 
Long-term lease liabilities  13,703   14,457 
Pension withdrawal liability  2,663   2,763 
Deferred income taxes  25,065   25,110 
Deferred compensation liability  17,330   14,850 
Earnout liabilities  45,433   44,898 
Other long-term liabilities  231   1,359 
           Total long-term liabilities  348,425   347,437 
           Total liabilities $458,039  $452,281 
COMMITMENTS AND CONTINGENCIES      
SHAREHOLDERS' EQUITY:      
Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,743,884 and 20,752,138 shares issued and outstanding as of June 28, 2026 and March 29, 2026, respectively  207   208 
Additional paid-in capital  22,750   32,678 
Retained earnings  524,425   500,142 
Accumulated other comprehensive income  822   981 
           Total shareholders’ equity  548,204   534,009 
           Total liabilities and shareholders’ equity $1,006,243  $986,290 


HAWKINS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
 
  Three months ended
  June 28,
2026
 June 29,
2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $28,254  $29,175 
Reconciliation to cash flows:    
          Depreciation and amortization  13,945   12,291 
          Change in fair value of earnout liabilities  535   (1,583)
          Operating leases  1,040   923 
          Gain on deferred compensation assets  (1,425)  (942)
          Stock compensation expense  2,235   2,212 
          Other, net  58   (25)
          Changes in operating accounts providing (using) cash:    
                    Trade receivables  (12,462)  (2,651)
                    Inventories  (1,474)  (8,487)
                    Accounts payable  2,218   (3,812)
                    Accrued liabilities  (6,448)  (6,735)
                    Lease liabilities  (1,269)  (973)
                    Income taxes  9,029   9,831 
                    Other, net  916   2,266 
                              Net cash provided by operating activities  35,152   31,490 
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property, plant, and equipment  (11,605)  (13,544)
Acquisitions  (3,600)  (151,328)
Proceeds from asset disposals  260   327 
                              Net cash used in investing activities  (14,945)  (164,545)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends declared and paid  (3,971)  (3,754)
Payroll taxes paid in exchange for shares withheld  (5,143)  (3,028)
Shares repurchased  (7,021)   
Payments on senior secured revolving loan  (5,000)  (10,000)
Payments for debt issuance costs     (764)
Borrowings on senior secured revolving loan  5,000   160,000 
Other  (9)   
                              Net cash (used in) provided by financing activities  (16,144)  142,454 
NET INCREASE IN CASH AND CASH EQUIVALENTS  4,063   9,399 
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD  3,914   5,103 
CASH AND CASH EQUIVALENTS, END OF PERIOD $7,977  $14,502 
     
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION    
Cash paid for interest $2,816  $3,286 
Noncash investing activities - capital expenditures in accounts payable $3,001  $1,493 


HAWKINS, INC.
REPORTABLE SEGMENTS (UNAUDITED)
(In thousands)
 
  Water
Treatment
 Food & Health Sciences Industrial Solutions Total
Three months ended June 28, 2026:        
Sales $158,293  $97,250  $60,132  $315,675 
Cost of sales - materials  (94,481)  (73,345)  (47,858)  (215,684)
Cost of sales - operational overhead  (18,316)  (4,630)  (3,038)  (25,984)
Gross profit  45,496   19,275   9,236   74,007 
Selling, general, and administrative expenses  (23,670)  (8,028)  (3,637)  (35,335)
Operating income  21,826   11,247   5,599   38,672 
Three months ended June 29, 2025:        
Sales $149,566  $89,177  $54,529  $293,272 
Cost of sales - materials  (89,159)  (65,814)  (42,848)  (197,821)
Cost of sales - operational overhead  (16,660)  (4,015)  (2,414)  (23,089)
Gross profit  43,747   19,348   9,267   72,362 
Selling, general, and administrative expenses  (19,085)  (8,381)  (3,563)  (31,029)
Operating income  24,662   10,967   5,704   41,333 
                 
                 

Forward-Looking Statements. Various remarks in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include those relating to consumer demand for products containing our ingredients and the impacts of those demands, expectations for results in our business segments and the timing of our filings with the Securities and Exchange Commission. These statements are not historical facts, but rather are based on our current expectations, estimates and projections, and our beliefs and assumptions. Forward-looking statements may be identified by terms, including “anticipate,” “believe,” “can,” “could,” “expect,” “intend,” “may,” “predict,” “should,” or “will” or the negative of these terms or other comparable terms. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. Actual results may vary materially from those contained in forward looking statements based on a number of factors, including, but not limited to, changes in competition and price pressures, changes in demand and customer requirements or processes for our products, availability of product and disruptions to supplies, interruptions in production resulting from hazards, transportation limitations or other extraordinary events outside our control that may negatively impact our business or the supply chains in which we participate, changes in imported products and tariff levels, the availability of products and the prices at which they are available, the acceptance of new products by our customers and the timing of any such acceptance, changes in product supplies, the availability of target acquisitions, and changes in interest rates. Additional information concerning potential factors that could affect future financial results is included in our Annual Report on Form 10-K for the fiscal year ended March 29, 2026, as updated from time to time in amendments and subsequent reports filed with the SEC. Investors should take such risks into account when making investment decisions. Shareholders and other readers are cautioned not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date hereof. We do not undertake any obligation to update any forward-looking statements.

Contacts:Jeffrey P. Oldenkamp
Executive Vice President and Chief Financial Officer
612/331-6910
ir@HawkinsInc.com

FAQ

How did Hawkins (HWKN) perform in Q1 fiscal 2027?

Hawkins delivered higher revenue but slightly lower earnings in Q1 fiscal 2027. According to Hawkins, sales rose 8% to $315.7 million, while net income declined 3% to $28.3 million and diluted EPS decreased 4% to $1.35 compared with the prior-year quarter.

What drove revenue growth for Hawkins (HWKN) in Q1 fiscal 2027 by segment?

Revenue growth was broad-based across all segments. According to Hawkins, Water Treatment sales increased 6% to $158.3 million, Food & Health Sciences rose 9% to $97.3 million, and Industrial Solutions grew 10% to $60.1 million, supported by higher volumes and contributions from acquired businesses.

What was Hawkins’ adjusted EBITDA in Q1 fiscal 2027 and how did it change?

Hawkins’ adjusted EBITDA for Q1 fiscal 2027 was $56.9 million, up 1% year over year. According to Hawkins, this record adjusted EBITDA reflects add-backs for interest, taxes, depreciation, amortization, non-cash compensation, acquisition expenses and earnout-related items under its revised non-GAAP definition.

How much free cash flow did Hawkins (HWKN) generate in Q1 fiscal 2027?

Hawkins generated significantly higher free cash flow in Q1 fiscal 2027. According to Hawkins, free cash flow rose to $23.5 million, up from $17.9 million a year earlier, based on $35.2 million of operating cash flow minus $11.6 million of capital expenditures for the quarter.

What capital allocation actions did Hawkins take in Q1 fiscal 2027?

Hawkins used its free cash flow for several capital allocation actions. According to Hawkins, the company repurchased $7.0 million of stock, paid $4.0 million in dividends, and acquired Aqua-Chem for $3.6 million, while also maintaining a leverage ratio of 1.36x adjusted EBITDA.

What is Hawkins’ debt and leverage position after Q1 fiscal 2027 results?

Hawkins reported moderate leverage following Q1 fiscal 2027. According to Hawkins, total debt outstanding was $244.0 million as of June 28, 2026, resulting in a leverage ratio of 1.36x trailing twelve‑month adjusted EBITDA, slightly improved from 1.37x at the end of fiscal 2026.

Did Hawkins (HWKN) change its dividend in Q1 fiscal 2027?

Hawkins modestly increased its dividend in Q1 fiscal 2027. According to Hawkins, cash dividends declared per common share were $0.19 for the quarter, compared with $0.18 in the prior-year period, alongside continued share repurchases and acquisition spending funded by free cash flow.